Global Antisense & RNAi Therapeutics Market Size, Industry Analysis By Segmentations, Top Key Players, Trends, Future Development & Forecast 2024-2035
- PUBLISHED ON
- 10/11/2022
- NO OF PAGES
- 224
- CATEGORY
- Healthcare & Life Sciences
The Antisense & RNAi Therapeutics market report is a perfect foundation for people looking out for a comprehensive study and analysis of the Antisense & RNAi Therapeutics market. On the basis of historic growth analysis and current scenario of Antisense & RNAi Therapeutics market place, the report intends to offer actionable insights and outlook on global / regional market growth projections. Authenticated data presented in report is based on findings of extensive primary and secondary research. Insights drawn from data serve as excellent tool that facilitate deeper understanding of multiple aspects of global Antisense & RNAi Therapeutics market. These further helps users with their developmental strategy.
This report examines all the key factors influencing growth of global Antisense & RNAi Therapeutics market, including demand-supply scenario, pricing structure, profit margins, production and value chain / ecosystem analysis. Regional assessment of global Antisense & RNAi Therapeutics market unlocks a plethora of untapped opportunities in regional and domestic market places. Detailed company profiling enables users to evaluate company shares analysis, emerging product lines, scope of NPD in new markets, pricing strategies, innovation possibilities and much more.
Global Antisense & RNAi Therapeutics Market: Major Players
Rxi Pharmaceuticals
Quark Pharmaceuticals
Silenseed
Rexhan Pharmaceuticals
Isis Pharmaceuticals/ Ionis Pharmaceuticals
Sanofi Aventis / Genzyme
Regulus Therapeutics
Arbutus Biopharma Ltd.
Silence Therapeutics
Calando Pharmaceuticals
Glaxo Smith Kline
ICo Therapeutics
Bio-Path Holdings Inc.
Dicerna Pharmaceuticals
Biomarin/Prosensa
Global Antisense & RNAi Therapeutics Market: By Types
RNA interference
SiRNA
MiRNA
Antisense RNA
Global Antisense & RNAi Therapeutics Market: By Applications
Oncology
Cardiovascular
Renal
Neurodegenerative
Respiratory
Genetic
Infectious Diseases
Global Antisense & RNAi Therapeutics Market: Regional Analysis
All the regional segmentation has been studied based on recent and future trends, and the market is forecasted throughout the prediction period. The countries covered in the regional analysis of the Global Antisense & RNAi Therapeutics market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), and Argentina, Brazil, and Rest of South America as part of South America.
Global Antisense & RNAi Therapeutics Market: Market Size Estimation
Both the top-down and bottom-up approaches were used to estimate and validate the size of the market and to estimate the size of various other dependent sub-markets of various marketspaces. The key players in the markets are identified through secondary research, and their market contributions in different applications across regions and globally were determined through primary and secondary research. This entire process included the study of the annual and financial reports of the top market players and extensive interviews for key insights with industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All the possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to arrive at the final quantitative and qualitative data. This data has been consolidated, and detailed inputs and analysis from Analytics Market Research added before being presented in this report.
Frequently Asked Questions
• What is the market size and growth projections?
• What is the market size and growth projection for each of the market segments and sub-segments across Countries & Regions?
• What are the top performing segments, and countries / regions of each of the markets?
• What is the market size and growth rate across key countries / regions?
• How big is the global & regional market in terms of revenue and volume?
• How far market will grow in forecast period in terms of revenue and volume?
• What factors will influence demand and supply trends across each markets during the forecast period?
• What are the technology trends shaping various markets?
• Which country / region has more opportunities?
• What is the COVID-19 impact on the market and how long will it take to recover?
• Who are the key competitors of market Players?
• What are the market share (%) of Key Players?
• What are the Merger & Acquisition, New Product Launch, Recent Development within each of the Markets?
• What are PEST analysis, Ecosystem Analysis, Porter's Five Forecast Analysis, Ansoff Matrix, and SWOT Analysis among other analyses for diverse markets?
Base Year: 2023This report examines all the key factors influencing growth of global Antisense & RNAi Therapeutics market, including demand-supply scenario, pricing structure, profit margins, production and value chain / ecosystem analysis. Regional assessment of global Antisense & RNAi Therapeutics market unlocks a plethora of untapped opportunities in regional and domestic market places. Detailed company profiling enables users to evaluate company shares analysis, emerging product lines, scope of NPD in new markets, pricing strategies, innovation possibilities and much more.
Global Antisense & RNAi Therapeutics Market: Major Players
Rxi Pharmaceuticals
Quark Pharmaceuticals
Silenseed
Rexhan Pharmaceuticals
Isis Pharmaceuticals/ Ionis Pharmaceuticals
Sanofi Aventis / Genzyme
Regulus Therapeutics
Arbutus Biopharma Ltd.
Silence Therapeutics
Calando Pharmaceuticals
Glaxo Smith Kline
ICo Therapeutics
Bio-Path Holdings Inc.
Dicerna Pharmaceuticals
Biomarin/Prosensa
Global Antisense & RNAi Therapeutics Market: By Types
RNA interference
SiRNA
MiRNA
Antisense RNA
Global Antisense & RNAi Therapeutics Market: By Applications
Oncology
Cardiovascular
Renal
Neurodegenerative
Respiratory
Genetic
Infectious Diseases
Global Antisense & RNAi Therapeutics Market: Regional Analysis
All the regional segmentation has been studied based on recent and future trends, and the market is forecasted throughout the prediction period. The countries covered in the regional analysis of the Global Antisense & RNAi Therapeutics market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), and Argentina, Brazil, and Rest of South America as part of South America.
Global Antisense & RNAi Therapeutics Market: Market Size Estimation
Both the top-down and bottom-up approaches were used to estimate and validate the size of the market and to estimate the size of various other dependent sub-markets of various marketspaces. The key players in the markets are identified through secondary research, and their market contributions in different applications across regions and globally were determined through primary and secondary research. This entire process included the study of the annual and financial reports of the top market players and extensive interviews for key insights with industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All the possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to arrive at the final quantitative and qualitative data. This data has been consolidated, and detailed inputs and analysis from Analytics Market Research added before being presented in this report.
Frequently Asked Questions
• What is the market size and growth projections?
• What is the market size and growth projection for each of the market segments and sub-segments across Countries & Regions?
• What are the top performing segments, and countries / regions of each of the markets?
• What is the market size and growth rate across key countries / regions?
• How big is the global & regional market in terms of revenue and volume?
• How far market will grow in forecast period in terms of revenue and volume?
• What factors will influence demand and supply trends across each markets during the forecast period?
• What are the technology trends shaping various markets?
• Which country / region has more opportunities?
• What is the COVID-19 impact on the market and how long will it take to recover?
• Who are the key competitors of market Players?
• What are the market share (%) of Key Players?
• What are the Merger & Acquisition, New Product Launch, Recent Development within each of the Markets?
• What are PEST analysis, Ecosystem Analysis, Porter's Five Forecast Analysis, Ansoff Matrix, and SWOT Analysis among other analyses for diverse markets?
Historic Year: 2016-2022
Forecast: 2024-2035
1 Antisense & RNAi Therapeutics Market Definition and Overview
1.1 Objectives of the Study
1.2 Overview of Antisense & RNAi Therapeutics
1.3 Antisense & RNAi Therapeutics Market Scope and Market Size Estimation
1.4 Market Segmentation
1.4.1 Types of Antisense & RNAi Therapeutics
1.4.2 Applications of Antisense & RNAi Therapeutics
1.5 Market Exchange Rate
2 Research Method and Logic
2.1 Methodology
2.2 Research Data Source
3 Market Competition Analysis
3.1 Rxi Pharmaceuticals Market Performance Analysis
3.1.1 Rxi Pharmaceuticals Basic Information
3.1.2 Product and Service Analysis
3.1.3 Strategies for Company to Deal with the Impact of COVID-19
3.1.4 Rxi Pharmaceuticals Sales, Value, Price, Gross Margin 2016-2021
3.2 Quark Pharmaceuticals Market Performance Analysis
3.2.1 Quark Pharmaceuticals Basic Information
3.2.2 Product and Service Analysis
3.2.3 Strategies for Company to Deal with the Impact of COVID-19
3.2.4 Quark Pharmaceuticals Sales, Value, Price, Gross Margin 2016-2021
3.3 Silenseed Market Performance Analysis
3.3.1 Silenseed Basic Information
3.3.2 Product and Service Analysis
3.3.3 Strategies for Company to Deal with the Impact of COVID-19
3.3.4 Silenseed Sales, Value, Price, Gross Margin 2016-2021
3.4 Rexhan Pharmaceuticals Market Performance Analysis
3.4.1 Rexhan Pharmaceuticals Basic Information
3.4.2 Product and Service Analysis
3.4.3 Strategies for Company to Deal with the Impact of COVID-19
3.4.4 Rexhan Pharmaceuticals Sales, Value, Price, Gross Margin 2016-2021
3.5 Isis Pharmaceuticals/ Ionis Pharmaceuticals Market Performance Analysis
3.5.1 Isis Pharmaceuticals/ Ionis Pharmaceuticals Basic Information
3.5.2 Product and Service Analysis
3.5.3 Strategies for Company to Deal with the Impact of COVID-19
3.5.4 Isis Pharmaceuticals/ Ionis Pharmaceuticals Sales, Value, Price, Gross Margin 2016-2021
3.6 Sanofi Aventis / Genzyme Market Performance Analysis
3.6.1 Sanofi Aventis / Genzyme Basic Information
3.6.2 Product and Service Analysis
3.6.3 Strategies for Company to Deal with the Impact of COVID-19
3.6.4 Sanofi Aventis / Genzyme Sales, Value, Price, Gross Margin 2016-2021
3.7 Regulus Therapeutics Market Performance Analysis
3.7.1 Regulus Therapeutics Basic Information
3.7.2 Product and Service Analysis
3.7.3 Strategies for Company to Deal with the Impact of COVID-19
3.7.4 Regulus Therapeutics Sales, Value, Price, Gross Margin 2016-2021
3.8 Arbutus Biopharma Ltd. Market Performance Analysis
3.8.1 Arbutus Biopharma Ltd. Basic Information
3.8.2 Product and Service Analysis
3.8.3 Strategies for Company to Deal with the Impact of COVID-19
3.8.4 Arbutus Biopharma Ltd. Sales, Value, Price, Gross Margin 2016-2021
3.9 Silence Therapeutics Market Performance Analysis
3.9.1 Silence Therapeutics Basic Information
3.9.2 Product and Service Analysis
3.9.3 Strategies for Company to Deal with the Impact of COVID-19
3.9.4 Silence Therapeutics Sales, Value, Price, Gross Margin 2016-2021
3.10 Calando Pharmaceuticals Market Performance Analysis
3.10.1 Calando Pharmaceuticals Basic Information
3.10.2 Product and Service Analysis
3.10.3 Strategies for Company to Deal with the Impact of COVID-19
3.10.4 Calando Pharmaceuticals Sales, Value, Price, Gross Margin 2016-2021
3.11 Glaxo Smith Kline Market Performance Analysis
3.11.1 Glaxo Smith Kline Basic Information
3.11.2 Product and Service Analysis
3.11.3 Strategies for Company to Deal with the Impact of COVID-19
3.11.4 Glaxo Smith Kline Sales, Value, Price, Gross Margin 2016-2021
3.12 ICo Therapeutics Market Performance Analysis
3.12.1 ICo Therapeutics Basic Information
3.12.2 Product and Service Analysis
3.12.3 Strategies for Company to Deal with the Impact of COVID-19
3.12.4 ICo Therapeutics Sales, Value, Price, Gross Margin 2016-2021
3.13 Bio-Path Holdings Inc. Market Performance Analysis
3.13.1 Bio-Path Holdings Inc. Basic Information
3.13.2 Product and Service Analysis
3.13.3 Strategies for Company to Deal with the Impact of COVID-19
3.13.4 Bio-Path Holdings Inc. Sales, Value, Price, Gross Margin 2016-2021
3.14 Dicerna Pharmaceuticals Market Performance Analysis
3.14.1 Dicerna Pharmaceuticals Basic Information
3.14.2 Product and Service Analysis
3.14.3 Strategies for Company to Deal with the Impact of COVID-19
3.14.4 Dicerna Pharmaceuticals Sales, Value, Price, Gross Margin 2016-2021
3.15 Biomarin/Prosensa Market Performance Analysis
3.15.1 Biomarin/Prosensa Basic Information
3.15.2 Product and Service Analysis
3.15.3 Strategies for Company to Deal with the Impact of COVID-19
3.15.4 Biomarin/Prosensa Sales, Value, Price, Gross Margin 2016-2021
4 Market Segment by Type, Historical Data and Market Forecasts
4.1 Global Antisense & RNAi Therapeutics Production and Value by Type
4.1.1 Global Antisense & RNAi Therapeutics Production by Type 2016-2021
4.1.2 Global Antisense & RNAi Therapeutics Market Value by Type 2016-2021
4.2 Global Antisense & RNAi Therapeutics Market Production, Value and Growth Rate by Type 2016-2021
4.2.1 RNA interference Market Production, Value and Growth Rate
4.2.2 SiRNA Market Production, Value and Growth Rate
4.2.3 MiRNA Market Production, Value and Growth Rate
4.2.4 Antisense RNA Market Production, Value and Growth Rate
4.3 Global Antisense & RNAi Therapeutics Production and Value Forecast by Type
4.3.1 Global Antisense & RNAi Therapeutics Production Forecast by Type 2022-2030
4.3.2 Global Antisense & RNAi Therapeutics Market Value Forecast by Type 2022-2030
4.4 Global Antisense & RNAi Therapeutics Market Production, Value and Growth Rate by Type Forecast 2022-2030
4.4.1 RNA interference Market Production, Value and Growth Rate Forecast
4.4.2 SiRNA Market Production, Value and Growth Rate Forecast
4.4.3 MiRNA Market Production, Value and Growth Rate Forecast
4.4.4 Antisense RNA Market Production, Value and Growth Rate Forecast
5 Market Segment by Application, Historical Data and Market Forecasts
5.1 Global Antisense & RNAi Therapeutics Consumption and Value by Application
5.1.1 Global Antisense & RNAi Therapeutics Consumption by Application 2016-2021
5.1.2 Global Antisense & RNAi Therapeutics Market Value by Application 2016-2021
5.2 Global Antisense & RNAi Therapeutics Market Consumption, Value and Growth Rate by Application 2016-2021
5.2.1 Oncology Market Consumption, Value and Growth Rate
5.2.2 Cardiovascular Market Consumption, Value and Growth Rate
5.2.3 Renal Market Consumption, Value and Growth Rate
5.2.4 Neurodegenerative Market Consumption, Value and Growth Rate
5.2.5 Respiratory Market Consumption, Value and Growth Rate
5.2.6 Genetic Market Consumption, Value and Growth Rate
5.2.7 Infectious Diseases Market Consumption, Value and Growth Rate
5.3 Global Antisense & RNAi Therapeutics Consumption and Value Forecast by Application
5.3.1 Global Antisense & RNAi Therapeutics Consumption Forecast by Application 2022-2030
5.3.2 Global Antisense & RNAi Therapeutics Market Value Forecast by Application 2022-2030
5.4 Global Antisense & RNAi Therapeutics Market Consumption, Value and Growth Rate by Application Forecast 2022-2030
5.4.1 Oncology Market Consumption, Value and Growth Rate Forecast
5.4.2 Cardiovascular Market Consumption, Value and Growth Rate Forecast
5.4.3 Renal Market Consumption, Value and Growth Rate Forecast
5.4.4 Neurodegenerative Market Consumption, Value and Growth Rate Forecast
5.4.5 Respiratory Market Consumption, Value and Growth Rate Forecast
5.4.6 Genetic Market Consumption, Value and Growth Rate Forecast
5.4.7 Infectious Diseases Market Consumption, Value and Growth Rate Forecast
6 Global Antisense & RNAi Therapeutics by Region, Historical Data and Market Forecasts
6.1 Global Antisense & RNAi Therapeutics Sales by Region 2016-2021
6.2 Global Antisense & RNAi Therapeutics Market Value by Region 2016-2021
6.3 Global Antisense & RNAi Therapeutics Market Sales, Value and Growth Rate by Region 2016-2021
6.3.1 North America
6.3.2 Europe
6.3.3 Asia Pacific
6.3.4 South America
6.3.5 Middle East and Africa
6.4 Global Antisense & RNAi Therapeutics Sales Forecast by Region 2022-2030
6.5 Global Antisense & RNAi Therapeutics Market Value Forecast by Region 2022-2030
6.6 Global Antisense & RNAi Therapeutics Market Sales, Value and Growth Rate Forecast by Region 2022-2030
6.6.1 North America
6.6.2 Europe
6.6.3 Asia Pacific
6.6.4 South America
6.6.5 Middle East and Africa
7 United State Market Size Analysis 2016-2026
7.1 United State Antisense & RNAi Therapeutics Value and Market Growth 2016-2021
7.2 United State Antisense & RNAi Therapeutics Sales and Market Growth 2016-2021
7.3 United State Antisense & RNAi Therapeutics Market Value Forecast 2022-2030
8 Canada Market Size Analysis 2016-2026
8.1 Canada Antisense & RNAi Therapeutics Value and Market Growth 2016-2021
8.2 Canada Antisense & RNAi Therapeutics Sales and Market Growth 2016-2021
8.3 Canada Antisense & RNAi Therapeutics Market Value Forecast 2022-2030
9 Germany Market Size Analysis 2016-2026
9.1 Germany Antisense & RNAi Therapeutics Value and Market Growth 2016-2021
9.2 Germany Antisense & RNAi Therapeutics Sales and Market Growth 2016-2021
9.3 Germany Antisense & RNAi Therapeutics Market Value Forecast 2022-2030
10 UK Market Size Analysis 2016-2026
10.1 UK Antisense & RNAi Therapeutics Value and Market Growth 2016-2021
10.2 UK Antisense & RNAi Therapeutics Sales and Market Growth 2016-2021
10.3 UK Antisense & RNAi Therapeutics Market Value Forecast 2022-2030
11 France Market Size Analysis 2016-2026
11.1 France Antisense & RNAi Therapeutics Value and Market Growth 2016-2021
11.2 France Antisense & RNAi Therapeutics Sales and Market Growth 2016-2021
11.3 France Antisense & RNAi Therapeutics Market Value Forecast 2022-2030
12 Italy Market Size Analysis 2016-2026
12.1 Italy Antisense & RNAi Therapeutics Value and Market Growth 2016-2021
12.2 Italy Antisense & RNAi Therapeutics Sales and Market Growth 2016-2021
12.3 Italy Antisense & RNAi Therapeutics Market Value Forecast 2022-2030
13 Spain Market Size Analysis 2016-2026
13.1 Spain Antisense & RNAi Therapeutics Value and Market Growth 2016-2021
13.2 Spain Antisense & RNAi Therapeutics Sales and Market Growth 2016-2021
13.3 Spain Antisense & RNAi Therapeutics Market Value Forecast 2022-2030
14 Russia Market Size Analysis 2016-2026
14.1 Russia Antisense & RNAi Therapeutics Value and Market Growth 2016-2021
14.2 Russia Antisense & RNAi Therapeutics Sales and Market Growth 2016-2021
14.3 Russia Antisense & RNAi Therapeutics Market Value Forecast 2022-2030
15 China Market Size Analysis 2016-2026
15.1 China Antisense & RNAi Therapeutics Value and Market Growth 2016-2021
15.2 China Antisense & RNAi Therapeutics Sales and Market Growth 2016-2021
15.3 China Antisense & RNAi Therapeutics Market Value Forecast 2022-2030
16 Japan Market Size Analysis 2016-2026
16.1 Japan Antisense & RNAi Therapeutics Value and Market Growth 2016-2021
16.2 Japan Antisense & RNAi Therapeutics Sales and Market Growth 2016-2021
16.3 Japan Antisense & RNAi Therapeutics Market Value Forecast 2022-2030
17 South Korea Market Size Analysis 2016-2026
17.1 South Korea Antisense & RNAi Therapeutics Value and Market Growth 2016-2021
17.2 South Korea Antisense & RNAi Therapeutics Sales and Market Growth 2016-2021
17.3 South Korea Antisense & RNAi Therapeutics Market Value Forecast 2022-2030
18 Australia Market Size Analysis 2016-2026
18.1 Australia Antisense & RNAi Therapeutics Value and Market Growth 2016-2021
18.2 Australia Antisense & RNAi Therapeutics Sales and Market Growth 2016-2021
18.3 Australia Antisense & RNAi Therapeutics Market Value Forecast 2022-2030
19 Thailand Market Size Analysis 2016-2026
19.1 Thailand Antisense & RNAi Therapeutics Value and Market Growth 2016-2021
19.2 Thailand Antisense & RNAi Therapeutics Sales and Market Growth 2016-2021
19.3 Thailand Antisense & RNAi Therapeutics Market Value Forecast 2022-2030
20 Brazil Market Size Analysis 2016-2026
20.1 Brazil Antisense & RNAi Therapeutics Value and Market Growth 2016-2021
20.2 Brazil Antisense & RNAi Therapeutics Sales and Market Growth 2016-2021
20.3 Brazil Antisense & RNAi Therapeutics Market Value Forecast 2022-2030
21 Argentina Market Size Analysis 2016-2026
21.1 Argentina Antisense & RNAi Therapeutics Value and Market Growth 2016-2021
21.2 Argentina Antisense & RNAi Therapeutics Sales and Market Growth 2016-2021
21.3 Argentina Antisense & RNAi Therapeutics Market Value Forecast 2022-2030
22 Chile Market Size Analysis 2016-2026
22.1 Chile Antisense & RNAi Therapeutics Value and Market Growth 2016-2021
22.2 Chile Antisense & RNAi Therapeutics Sales and Market Growth 2016-2021
22.3 Chile Antisense & RNAi Therapeutics Market Value Forecast 2022-2030
23 South Africa Market Size Analysis 2016-2026
23.1 South Africa Antisense & RNAi Therapeutics Value and Market Growth 2016-2021
23.2 South Africa Antisense & RNAi Therapeutics Sales and Market Growth 2016-2021
23.3 South Africa Antisense & RNAi Therapeutics Market Value Forecast 2022-2030
24 Egypt Market Size Analysis 2016-2026
24.1 Egypt Antisense & RNAi Therapeutics Value and Market Growth 2016-2021
24.2 Egypt Antisense & RNAi Therapeutics Sales and Market Growth 2016-2021
24.3 Egypt Antisense & RNAi Therapeutics Market Value Forecast 2022-2030
25 UAE Market Size Analysis 2016-2026
25.1 UAE Antisense & RNAi Therapeutics Value and Market Growth 2016-2021
25.2 UAE Antisense & RNAi Therapeutics Sales and Market Growth 2016-2021
25.3 UAE Antisense & RNAi Therapeutics Market Value Forecast 2022-2030
26 Saudi Arabia Market Size Analysis 2016-2026
26.1 Saudi Arabia Antisense & RNAi Therapeutics Value and Market Growth 2016-2021
26.2 Saudi Arabia Antisense & RNAi Therapeutics Sales and Market Growth 2016-2021
26.3 Saudi Arabia Antisense & RNAi Therapeutics Market Value Forecast 2022-2030
27 Market Dynamic Analysis and Development Suggestions
27.1 Market Drivers
27.2 Market Development Constraints
27.3 PEST Analysis
27.3.1 Political Factors
27.3.2 Economic Factors
27.3.3 Social Factors
27.3.4 Technological Factors
27.4 Industry Trends Under COVID-19
27.4.1 Risk Assessment on COVID-19
27.4.2 Assessment of the Overall Impact of COVID-19 on the Industry
27.4.3 Pre COVID-19 and Post COVID-19 Market Scenario
27.5 Market Entry Strategy Analysis
27.5.1 Market Definition
27.5.2 Client
27.5.3 Distribution Model
27.5.4 Product Messaging and Positioning
27.5.5 Price
27.6 Advice on Entering the Market
Quality Assurance Process
- We Market Research’s Quality Assurance program strives to deliver superior value to our clients.
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
- Project kickoff meeting with client
- Conduct frequent client communications
- Form project steering committee
- Assign a senior SR executive as QA Executive
- Conduct internal editorial & quality reviews of project deliverables
- Certify project staff in SR methodologies & standards
- Monitor client satisfaction
- Monitor realized value post-project
Case Study- Automotive Sector
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached Straits Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
Solution
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
Market Estimates and Forecast
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Case Study- ICT Sector
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
Business Solution
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
Conclusion
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2028.
}})
Pricing
Select a license type that suits your business needs
Single User Access
US $3950
Only Three Thousand Nine Hundred Fifty US dollar
- 1 User access
- 15% Additional Free Customization
- Free Unlimited post-sale support
- 100% Service Guarantee until achievement of ROI
Multi User Cost
US $4950
Only Four Thousand Nine Hundred Fifty US dollar
- 5 Users access
- 25% Additional Free Customization
- Access Report summaries for Free
- Guaranteed service
- Dedicated Account Manager
- Discount of 20% on next purchase
- Get personalized market brief from Lead Author
- Printing of Report permitted
- Discount of 20% on next purchase
- 100% Service Guarantee until achievement of ROI
Enterprise User Cost
US $5950
Only Five Thousand Nine Hundred Fifty US dollar
- Unlimited User Access
- 30% Additional Free Customization
- Exclusive Previews to latest or upcoming reports
- Discount of 30% on next purchase
- 100% Service Guarantee until achievement of ROI